Methamphetamine-induced deficits of brain monoaminergic neuronal markers: distal axotomy or neuronal plasticity (Q44654013)

5 December 2017

title

Methamphetamine-induced deficits of brain monoaminergic neuronal markers: distal axotomy or neuronal plasticity (English)

1 reference

5 December 2017

1 reference

Guilarte TR

1

1 reference

5 December 2017

Nihei MK

series ordinal

2

1 reference

5 December 2017

McGlothan JL

series ordinal

3

1 reference

5 December 2017

Howard AS

series ordinal

4

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

5 December 2017

number of pages

15

1 reference

inferred from page(s)

published in

Neuroscience

1 reference

5 December 2017

volume

122

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

499-513

1 reference

Immunocytochemical evidence for methamphetamine-induced serotonergic axon loss in the rat brain

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Induction of 'rage' following microinjections of glutamate into midbrain but not hypothalamus of cats

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Modification of dopamine transporter function: effect of reactive oxygen species and dopamine.

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Parenterally administered 3-nitropropionic acid and amphetamine can combine to produce damage to terminals and cell bodies in the striatum

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Methamphetamine selectively damages dopaminergic innervation to the nucleus accumbens core while sparing the shell

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Effects of high-dose methamphetamine on monoamine uptake sites in rat brain measured by quantitative autoradiography

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Time-course of methamphetamine-induced neurotoxicity in rat caudate-putamen after single-dose treatment

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Attenuation and recovery of evoked overflow of striatal serotonin in rats treated with neurotoxic doses of methamphetamine

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine.

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress.

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Involvement of the periaqueductal grey matter and spinal 5-hydroxytryptaminergic pathways in morphine analgesia: effcts of lesions and 5-hydroxytryptamine depletion

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamine

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Immunocytochemical Localization of β-Endorphin-Containing Neurons in the Rat Brain

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter.

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

A single dose model of methamphetamine-induced neurotoxicity in rats: effects on neostriatal monoamines and glial fibrillary acidic protein

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis1Published on the World Wide Web on 27 January 1998.1

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Monoamine transporters: from genes to behavior

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Protein kinase C and dopamine transport--1. Effects of amphetamine in vivo

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Protein kinase C and dopamine transport--2. Effects of amphetamine in vitro

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations.

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter.

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Profound neuronal plasticity in response to inactivation of the dopamine transporter

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Some perspectives on monoamine-opioid peptide interaction in rat central nervous system

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Repeated reserpine administration reduces in vivo [18F]GBR 13119 binding to the dopamine uptake site

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein: possible endogenous toxin to serotonin neurons

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Regional and temporal expression of the peripheral benzodiazepine receptor in MPTP neurotoxicity

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine.

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Properties and localization of beta-endorphin receptor in rat brain

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Chronic infusion of a melanocortin receptor agonist modulates dopamine receptor binding in the rat brain

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Fluorescence histochemistry indicates damage of striatal dopamine nerve terminals in rats after multiple doses of methamphetamine

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Influence of the dorsal and median raphe nuclei on neurons in the periaqueductal gray matter: role of 5-hydroxytryptamine.

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Membrane trafficking regulates the activity of the human dopamine transporter

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Behavioral sensitization to cocaine after a brief social defeat stress: c-fos expression in the PAG.

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Short-term treatments with haloperidol or bromocriptine do not alter the density of the monoamine vesicular transporter in the substantia nigra

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Monoaminergic regulation of the levels of beta-endorphin-like immunoreactivity (beta-ENDi) in rat hypothalamic nuclei

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Quantitative aspects of reactive gliosis: a review

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Quantitative aspects of drug and toxicant-induced astrogliosis

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Neurotoxic effects of substituted amphetamines in rats and mice

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Regulated trafficking of neurotransmitter transporters: common notes but different melodies

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Histological and ultrastructural evidence that D-amphetamine causes degeneration in neostriatum and frontal cortex of rats

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Withdrawal of repeated cocaine decreases autoradlographic [3H]mazindol-labelling of dopamine transporter In rat nucleus aecumbens

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Treatment of mice with methamphetamine produces cell loss in the substantia nigra

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Dopamine affects the in vitro basal secretion of rat placenta opioids in an opioid and dopamine receptor type-specific manner

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Role of the medullary raphé in thermoregulatory vasomotor control in rats

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

The vesicular monoamine transporter is not regulated by dopaminergic drug treatments

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Brain Dopamine Neurotoxicity in Baboons Treated with Doses of Methamphetamine Comparable to Those Recreationally Abused by Humans: Evidence from [11C]WIN-35,428 Positron Emission Tomography Studies and DirectIn VitroDeterminations

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Dopamine transporter cysteine mutants: second extracellular loop cysteines are required for transporter expression.

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Body temperature effects of opioids administered into the periaqueductal grey area of rat brain

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Chronic L-deprenyl-induced up-regulation of the dopamine uptake carrier

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

Serotonin transporters in the rat frontal cortex: lack of circadian rhythmicity but down-regulation by food restriction.

1 reference

https://api.crossref.org/works/10.1016/S0306-4522(03)00476-7

7 January 2021

10.1016/S0306-4522(03)00476-7

Identifiers

DOI

1 reference

5 December 2017

1 reference